Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06765226 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Impella Pump Return Study to Analyze Deposits and Biomaterial in Used Pumps

StatusRecruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Trial status: Not Yet Recruiting to Recruiting
    • Start date changed from estimate of Aug 1, 2025 to Sep 21, 2025
    • Site details revised at 7 of 7 sites
    v3
  2. Start date: Apr 1, 2025 to Aug 1, 2025v2 Show 4 more changesShow less
    • Study sites: 2 to 7
    • Primary completion date: Mar 31, 2030 to Jul 31, 2030
    • Study completion date: Sep 30, 2030 to Jan 31, 2031
    • Eligibility criteria shortened, about 13 words
  3. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Abiomed Inc.
13 trials monitored
See 1 trial at risk
Heart Disease
8,786 trials monitored
See 412 trials at risk
Heart Failure
1,995 trials monitored
See 111 trials at risk
Analysis of cell and protein deposits on the Impella Heart Pump.
Trial Details
NCT Number NCT06765226
Lead Sponsor Abiomed Inc.
Conditions
(from sponsor)		 Heart Failure
Related terms Heart Failure
Enrollment 200 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov